Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression

International Journal of Molecular Medicine

Volumn 35, Issue 6, 2015, Pages 1729-1733

  Zhou, Yanhong ^a   Hu, Zhaohui ^a   Li, Ningning ^a   Jiang, Renjie ^a  

^a LIUZHOU PEOPLE S HOSPITAL   (China)

Author keywords

AKT; Interleukin 32; Invasion; Matrix metalloproteinase 13; Motility; Osteosarcoma

Indexed keywords

BETA ACTIN; COLLAGENASE 3; INTERLEUKIN 32; MESSENGER RNA; PROTEIN KINASE B; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MMP13 PROTEIN, HUMAN;

ARTICLE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METASTASIS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKINS; MATRIX METALLOPROTEINASE 13; NEOPLASM INVASIVENESS; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84928400834     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2159     Document Type: Article

References (30)

1. Heare T, Hensley MA and Dell'Orfano S: Bone tumors: osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr 21: 365-372, 2009
2. Broadhead ML, Clark JC, Myers DE, Dass CR and Choong PF: The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011: 959248, 2011
3. Kakhki VR, Anvari K, Sadeghi R, Mahmoudian AS and Torabian-Kakhki M: Pattern and distribution of bone metastases in common malignant tumors. Nucl Med Rev Cent East Eur 16: 66-69, 2013
4. Wu PK, Chen WM, Chen CF, Lee OK, Haung CK and Chen TH: Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients. Jpn J Clin Oncol 39: 514-522, 2009
5. Sheu BC, Chang WC, Cheng CY, Lin HH, Chang DY and Huang SC: Cytokine regulation networks in the cancer microenvironment. Front Biosci 13: 6255-6268, 2008
6. Wilson J and Balkwill F: The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12: 113-120, 2002
7. Kim SH, Han SY, Azam T, Yoon DY and Dinarello CA: Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22: 131-142, 2005
8. Netea MG, Azam T, Ferwerda G, et al: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102: 16309-16314, 2005
9. Choi JD, Bae SY, Hong JW, et al: Identification of the most active interleukin-32 isoform. Immunology 126: 535-542, 2009
10. Yagi Y, Andoh A, Imaeda H, et al: Interleukin-32a expression in human colonic subepithelial myofibroblasts. Int J Mol Med 27: 263-268, 2011
11. Yousif NG, Al-Amran FG, Hadi N, Lee J and Adrienne J: Expression of IL-32 modulates NF-kappaB and p38 MAP kinase pathways in human esophageal cancer. Cytokine 61: 223-227, 2013
12. Lee HJ, Liang ZL, Huang SM, et al: Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma. Oncol Lett 3: 490-496, 2012
13. Joosten LA, Heinhuis B, Netea MG and Dinarello CA: Novel insights into the biology of interleukin-32. Cell Mol Life Sci 70: 3883-3892, 2013
14. Kang YH, Park MY, Yoon DY, et al: Dysregulation of overexpressed IL-32alpha in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-kappaB and Bcl-2. Cancer Lett 318: 226-233, 2012
15. Oh JH, Cho MC, Kim JH, et al: IL-32gamma inhibits cancer cell growth through inactivation of NF-kappaB and STAT3 signals. Oncogene 30: 3345-3359, 2011
16. Chang CJ, Chien Y, Lu KH, et al: Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. Biochem Biophys Res Commun 415: 245-251, 2011
17. Nold-Petry CA, Rudloff I, Baumer Y, et al: IL-32 promotes angiogenesis. J Immunol 192: 589-602, 2014
18. Ishigami S, Arigami T, Uchikado Y, et al: IL-32 expression is an independent prognostic marker for gastric cancer. Med Oncol 30: 472, 2013
19. Sorrentino C and Di Carlo E: Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 180: 769-779, 2009
20. Park JS, Choi SY, Lee JH, et al: Interleukin-32beta stimulates migration of MDA-MB-231 and MCF-7 cells via the VEGF-STAT3 signaling pathway. Cell Oncol (Dordr) 36: 493-503, 2013
21. Tsai CY, Wang CS, Tsai MM, et al: Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis. Clin Cancer Res 20: 2276-2288, 2014
22. Zeng Q, Li S, Zhou Y, et al: Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression. Cytokine 65: 24-32, 2014
23. Mabilleau G and Sabokbar A: Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. PLoS One 4: e4173, 2009
24. Cho KS, Park SH, Joo SH, Kim SH and Shin CY: The effects of IL-32 on the inflammatory activation of cultured rat primary astrocytes. Biochem Biophys Res Commun 402: 48-53, 2010
25. Felaco P, Castellani ML, De Lutiis MA, et al: IL-32: a newly-discovered proinflammatory cytokine. J Biol Regul Homeost Agents 23: 141-147, 2009
26. Brader S and Eccles SA: Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 90: 2-8, 2004
27. Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP and Lopez-Otin C: Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 107: 45-53, 1999
28. Ye Z, Jingzhong L, Yangbo L, Lei C and Jiandong Y: Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression. Oncol Res 21: 201-207, 2014
29. Osaki M, Takeshita F, Sugimoto Y, et al: MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 19: 1123-1130, 2011
30. Ma O, Cai WW, Zender L, et al: MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res 69: 2559-2567, 2009.